GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights
Go back to GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights| (NASDAQ: WGS) | Delayed: 101.10 -3.85 (3.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.95 | 52 Week High | $ | |||
| Open | $104.59 | 52 Week Low | $ | |||
| Day High | $105.00 | P/E | N/A | |||
| Day Low | $99.70 | EPS | $ | |||
| Volume | 786,130 | |||||

